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Abstract
Background: Commensal bacteria like Neisseria meningitidis sometimes cause serious disease. However, genomic
comparison of hyperinvasive and apathogenic lineages did not reveal unambiguous hints towards indispensable
virulence factors. Here, in a systems biological approach we compared gene expression of the invasive strain MC58
and the carriage strain α522 under different ex vivo conditions mimicking commensal and virulence compartments
to assess the strain-specific impact of gene regulation on meningococcal virulence.
Results: Despite indistinguishable ex vivo phenotypes, both strains differed in the expression of over 500 genes
under infection mimicking conditions. These differences comprised in particular metabolic and information
processing genes as well as genes known to be involved in host-damage such as the nitrite reductase and
numerous LOS biosynthesis genes. A model based analysis of the transcriptomic differences in human blood
suggested ensuing metabolic flux differences in energy, glutamine and cysteine metabolic pathways along with
differences in the activation of the stringent response in both strains. In support of the computational findings,
experimental analyses revealed differences in cysteine and glutamine auxotrophy in both strains as well as a strain
and condition dependent essentiality of the (p)ppGpp synthetase gene relA and of a short non-coding AT-rich
repeat element in its promoter region.
Conclusions: Our data suggest that meningococcal virulence is linked to transcriptional buffering of cryptic
genetic variation in metabolic genes including global stress responses. They further highlight the role of
regulatory elements for bacterial virulence and the limitations of model strain approaches when studying
such genetically diverse species as N. meningitidis.
Keywords: Neisseria meningitidis, Virulence, Regulatory evolution, Systems biology, Metabolism, Cryptic genetic
variation, Stringent response, MITE, RelA
Background
The human body is home to a vast number of different
bacterial species, and the overwhelming complexity of
the human microbiome has only very recently been fully
uncovered [1]. Although the majority of these colonizing
bacteria seem to be harmless or even beneficial com-
mensals, some have long been known to be Janus-faced,
and Neisseria meningitidis is a particularly prominent
example in this respect. On the one hand, this β-
proteobacterium is an exclusively human-adapted com-
mensal that is carried in the nasopharynx of about 20%
of the healthy population [2]. On the other hand, N.
meningitidis is also a ferocious pathogen that can cause
life-threatening invasive meningococcal disease (IMD),
and “no other infection so quickly slays” [3]. After cross-
ing the mucosal barrier and entering the bloodstream,
meningococci can cause septicemia, and by crossing the
blood–brain barrier and multiplying in the cerebrospinal
fluid (CSF) also acute bacterial meningitis, both often
within less than 24 h [4].
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In many commensal pathogens like Escherichia coli,
often the only difference between a pathogenic and a
non-pathogenic strain is a small set of so called viru-
lence genes [5]. By definition, a virulence gene is a gene
whose loss specifically impairs virulence but not viability
in rich media and which should be associated exclusively
with pathogenic but not with non-pathogenic strains of
a species [6]. However, with respect to gene content
meningococcal strains isolated from healthy carriers and
IMD patients are almost indistinguishable [7], and many
of the so called meningococcal virulence genes have also
been found in purely commensal neisserial species [8].
The analysis of meningococcal population genetic struc-
ture by multilocus sequence typing (MLST) demon-
strated that disease-causing meningococci do belong to
particular groups of related sequence types (STs), termed
clonal complexes (CCs), which are overrepresented in
disease isolates relative to their carriage prevalences and
are responsible for most disease [2]. Accordingly, these
data indicate that the propensity to cause invasive dis-
ease is somehow associated with the genetic make-up of
hyperinvasive lineages. Experimental observations along
with epidemiological models further indicate that genetic
differences in metabolic genes might have a central role
in the observed virulence differences among different
lineages in a yet to define manner [9, 10].
Alongside the well-established significance of gene
content variation in creating genetic diversity in the bac-
terial world, regulatory evolution is increasingly ac-
knowledged to substantially contribute to this diversity
[11]. Mutations affecting gene expression regulation en-
compass differences in the coding sequences of tran-
scription factors (TF) acting in trans and thus affecting
the expression of entire regulons [12, 13], as well as
sequence differences in the regulatory regions acting in
cis on the expression of downstream genes (e.g. [14]). By
acquiring functionally divergent homologous promoter
regions through horizontal transfer bacterial genes were
shown to rapidly shift between multiple regulatory
modes affecting, for example, up to 15% of the meningo-
coccal core genome [15]. In addition, also mutations in
metabolic genes can indirectly cause compensatory
changes in gene expression regulation of other house-
keeping genes to maintain cellular homeostasis. The en-
suing differential regulation of conserved genes can
mediate phenotypic traits that distinguish closely related
bacterial species [16] or even strains of the same species
[17]. In consequence, also the expression of a virulence-
associated gene could be epistatic and thus depend on
the genetic background of the respective strain (gene-
gene interaction, G x G) [18] and/or the environment
(gene-environment interaction, G x E) [19]. Given the
high genetic diversity of N. meningitidis [2], a virulence
gene candidate should consequently be differently
expressed between an invasive and a commensal strain
under disease mimicking conditions but not under con-
ditions mimicking the commensal state. In addition,
although the correlation between when genes are im-
portant for fitness and when those genes are upregulated
was shown to be small [20], the fitness of a knock-out
strain should differ between an invasive and a com-
mensal strain (G × G) under conditions mimicking inva-
sive infection (G × E).
The strict tropism of N. meningitidis for humans has
so far impeded the development of a suitable animal
model to analyze the course of meningococcal infection
in vivo, and therefore alternative experimental ap-
proaches such as ex vivo models have been established
to study meningococcal infection biology. For example,
human whole blood served as an ex vivo model to
analyze how meningococci regulate gene expression to
permit survival in human bloodstream during septicemia
[21, 22]. Likewise, meningococcal resistance to human
complement was studied in an ex vivo model using hu-
man CSF [23], and human saliva has already been used
to study ex vivo the transcriptional response which en-
ables meningococci to adapt to this relevant host niche
[24]. However, most of these ex vivo studies analyzed
gene expression only under a single condition and/or
used only a single strain from a hyperinvasive lineage.
Consequently, our knowledge about how this com-
mensal pathogen adapts during the transition from
colonization to an invasive infection is still very limited,
and nothing is known so far about gene expression or
phenotypic variability between carriage and hyperinva-
sive strains in conditions mimicking invasive infection.
In a systems biological approach we used different
ex vivo conditions as environmental perturbation and
natural genetic variation as genetic perturbation of the
meningococcal gene expression network and considered
gene expression as quantitative intermediate phenotype
[25, 26]. Based on prior population genetic information
we selected two genetically related meningococcal ser-
ogroup B strains from the same phylogenetic clade
PC32/269 [27, 28] with yet markedly different epidemi-
ology (Table 1 and Additional file 1: Figure S1) [2].
Strain MC58 belonging to the hyperinvasive ST-32 CC
was chosen as a reference as this strain has already
served as a model system to experimentally study men-
ingococcal infection biology in vitro and a large body of
transcriptomic data is thus available [21, 22, 29–34]. The
carriage strain α522 belongs to the carriage ST-35 CC
which is a four locus variant of the ST-32 CC sharing
about 96% of its genes with strain MC58 [28]. We com-
bined phenotypic, genomic and transcriptomic compari-
sons with mutagenesis studies to seek genetic variants
that influence meningococcal gene expression in human
saliva, whole blood and CSF mimicking commensal and
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virulence compartments, respectively. Gene expression
was analyzed in a strain- and condition-dependent man-
ner with particular emphasis on virulence-associated
genes and genes involved in gene expression regulation.
The combined data show that transcriptomic buffering
of cryptic genetic variation, which is the genetic vari-
ation present in the meningococcal population that is
not phenotypically expressed under commensal condi-
tions but visible upon environmental or genetic pertur-
bations such as growth in human blood [35, 36],
contributes to the regulatory evolution of meningococcal
virulence. We further demonstrate that it is likely af-
fected by the differential presence of a short, non-coding
inverted-repeat transposable-element in the promoter
region of relA encoding the guanosine 3'-(tri)dipho-
sphate 5-'diphosphate ((p)ppGpp) synthetase of the
stringent response pathway.
Results
MC58 and α522 have similar gene content including most
genes invovled in host interactions but with function-
dependent sequence variation among orthologs
In order to comprehensively analyze genetic differences
between both strains we generated a draft sequence of
the α522 genome for comparative genome expression
analyses (Table 1, Additional file 1: Figure S2A). The
common genomic backbone of both strains comprises
1.93 Mbp and encodes 1757 orthologous proteins with
an average BLASTP bit score ratio (BSRP) of 0.958
(95%-confidence interval (CI) = [0.513, 1.000]), corre-
sponding to an average amino acid identity of 99.4%
(95%-CI = [81.6%, 100%]). Notably, there was a signifi-
cant variation of the BSRPs of orthologous proteins with
respect to the COG functional category [37] (Kruskal-
Wallis rank sum test, p < 0.05) (Additional file 1: Figure
S2B). The 10% most divergent orthologous genes (BSRP
< 0.933, n = 177) were significantly enriched for genes in-
volved in cell motility (COG N, odds ratio (OR) = 3.8,
false discovery rate (FDR) = 0.031, Fisher’s exact test with
Benjamini-Hochberg multiple testing correction) as well
as secretion and transport (COG U, OR = 2.6, FDR <
0.05). The latter included numerous surface antigens
involved in host interactions such as the major type IV
pilus subunit protein PilE, the major outer membrane
proteins PorA and PorB, the autotransporters App
(NMB1985) and NalP (NMB1969), as well as proteins
involved in iron acquisition like the transferrin-binding
protein B and the lactoferrin-binding protein B. Com-
pared to the 10% most divergent orthologous genes,
identical genes (n = 825) were significantly enriched for
genes involved in energy production and conversion
(COG C, OR = 6.9, FDR < 0.01), carbohydrate transport
and metabolism (COG G, OR > 1.6, FDR < 0.05), amino
acid biosynthesis (COG E, OR = 1.7, FDR < 0.01) and
Table 1 Strains used for ex vivo transcriptome comparisons
α522 MC58
Genome characteristics
GenBank accession number FR845693 to
FR845718
AE002098
No. of contigs in final assembly 21 1
Average single base coverage 79-fold 8.4-fold
Genome size (bp) ≥2,074,170 2,272,360
GC content (%) 51.78% 51.53%
Predicted number of coding
sequences
≥1985 2063
Reference This work Tettelin et al.
(2000) [123]
Molecular epidemiology
Source Carrier Patient
Country and year of isolation Germany 2000 United Kingdom
1983
Sequence type ST-35 ST-74
Clonal complex (CC) ST-35 ST-32
Phylogenetic clade (PC) (a) PC32/269 PC32/269
Frequency of CC in carriers(b) 5.47% 4.99%
Disease/carriage ratio(c) 0.5 3.5
Reference Claus et al.
(2005) [100]
McGuiness et al.
(1991) [101]
Phenotypic characterization
Serum resistance (%)(d) 117.7 ± 23.8 116.3 ± 15.7
Adhesion to epithelial cells(e)
FaDu cells (%) 10.7 ± 7.4 14.5 ± 8.5
Detroit562 cells (%) 8.9 ± 1.8 17.1 ± 5.3
Invasion of epithelial cells(e)
FaDu cells (%) 0.0008 ± 0.0001 0.0020 ± 0.0011
Detroit562 cells (%) 0.0011 ± 0.0004 0.0016 ± 0.0007
In vitro logarithmic growth rates(f)
Rich medium (PPM+) (1/h) 0.46 ± 0.01 0.47 ± 0.01
Minimal medium (MMM) (1/h) 0.06 ± 0.01 0.52 ± 0.02
Ex vivo growth rates(g)
Saliva (1/min) −0.041 ± 0.003 −0.043 ± 0.003
Blood (1/min) 0.027 ± 0.004 0.023 ± 0.002
CSF (1/min) 0.010 ± 0.002 0.018 ± 0.003
(a) According to ref. [27, 28]
(b) According to ref. [100]
(c) According to ref. [2]
(d) Ratio in percent of viable bacteria after incubation for 30 min in the
presence of 10% human serum and viable bacteria incubated without
serum. Given are the average and standard deviation from four
independent experiments with pooled human serum
(e) Ratio in percent of adherent and invasive bacteria, respectively, to total
bacteria. Given are the average and standard deviation from at least four
independent experiments
(f) Given are the mean and standard deviation of the logarithmic growth rate k
according to log(OD600(t)/OD600(0)) = kt for t ∈ [1 h, 4 h] as depicted in Fig. 5
using linear regression (R2in vitro = 0.96 ± 0.07, pin vitro = 0.013 ± 0.026)
(g) Given are the mean and standard deviation of the growth rate k according
to log(N(t)/N(0)) = kt for t ∈ [0 min, 120 min] as depicted in Fig. 5 using
linear regression (R2ex vivo = 0.95 ± 0.05, pex vivo = 0.018 ± 0.016)
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translation, ribosomal structure and biogenesis (COG J,
OR = 5.3, FDR < 0.001) (see Additional file 2: S1). Of the
135 genes coding for putative virulence factors or in-
volved in meningococcal host interactions in strain
MC58 (compiled from ref. [21, 38–40], see Additional
file 2: S1) only 8 are missing in strain α522, and strain
α522 lacks in particular large parts of the islands of hori-
zontal transfer B and C that code for a two-partner se-
cretion system involved in host cell adhesion [41]
(Additional file 1: Figure S2A). It further lacks almost
the entire repeat-in-toxin island 1 encoding FrpA/C-like
proteins which induce high levels of serum antibodies
during invasive disease in humans [42]. In addition,
downstream of glnB encoding the signal-transducing ni-
trogen regulatory protein PII strain α522 also lacks nadA
which codes for a minor adhesin that was found to pro-
mote bacterial adhesion to and penetration into human
epithelial cells in vitro [43]. MC58 further harbors a
30 kb duplication spanning 37 coding sequences involv-
ing the cysGHDNJI genes for sulfur acquisition which is
missing in α522 as in most other meningococcal
genomes.
Both strains display similar phenotypes in ex vivo fitness
and in vitro cell culture assays indicative of phenotypic
buffering
Despite the genetic differences described above, both
strains were phenotypically similar with respect to re-
sistance against human serum, adhesion to and inva-
sion of nasopharyngeal cell lines, respectively, as well
as in ex vivo growth (Table 1). Surprisingly, although
meningococci are part of the human oral microbiome
both strains were not able to grow in human saliva.
Since strain MC58 was able to grow in meningococ-
cal minimal medium (MMM), the observed growth
inhibitory effect of human saliva was probably not
due to nutrient limitation but more likely caused by
the presence of growth inhibiting substances known
to be present in human saliva like antimicrobial pep-
tides [44]. Of note, in their ecological niche, the hu-
man nasopharynx, meningococci are attached to host
cells in the form of microcolonies and are unlikely to
grow in a planktonic state as in the ex vivo situation
[45, 46]. The fact that bacteria in biofilms are less
susceptible to antimicrobial agents and host immune
responses thereby becoming persistent colonizers [47]
might explain the unexpected ex vivo growth pheno-
type in saliva. Furthermore, both strains grew equally
well in human blood and CSF and thus under disease
mimicking conditions despite their about 7-fold differ-
ence in the disease/carriage ratio (Table 1). These
data indicate that the ability to survive in human
blood is obviously necessary but per se not sufficient
to cause IMD.
We therefore focused on compensatory mechanisms
which might buffer the genotypic differences described
above under ex vivo conditions and considered the tran-
scriptome as an intermediate phenotype [25, 26]. We
hypothesized that both strains differ in the way they
accomplish growth under disease mimicking conditions
by differential transcriptional activation of metabolic and
stress response pathways. For convenience, comparisons
of the MC58 transcriptomes between saliva, whole blood
and CSF, respectively, will be called cross-condition com-
parisons and discussed only briefly in the main text and in
more detail in the Additional file 1. Likewise, comparisons
of the transcriptomes of strain MC58 and α522 in saliva,
whole blood and CSF, respectively, will be called cross-
strain comparisons (Additional file 1: Figure S1). Genes
differently expressed between two conditions or between
both strains in a given condition will be called differently
expressed genes, and genes differently regulated between
both strains between two conditions will shortly be called
differently regulated genes. Throughout the following ana-
lyses, we further discern directional and non-directional
classes of gene sets. The non-directional class of signifi-
cantly differently expressed genes contains genes where
the information about direction of differential expression
is omitted, so that significant gene sets can be interpreted
as affected by differential expression in general. The direc-
tional class aims to identify gene sets that are significantly
affected by regulation in a distinct direction, i. e. condition
or strain. If a gene set contains significantly expressed
genes in both directions, they will cancel out and the dir-
ectional FDR-value will not be significant. In turn, if a
gene set is not significantly enriched for differently
expressed genes in general it might nonetheless comprise
mainly genes with a significant expression bias in one dir-
ection. It consequently will have a non-significant non-
directional FDR-value but a significant directional FDR-
value.
Condition-dependent expression changes affect 24% of
the MC58 transcriptome
Of the 1987 genes assayed in the cross-condition
comparisons in strain MC58, 429 genes were differ-
ently expressed between saliva and blood and 151 be-
tween blood and CSF, respectively (Fig. 1a, c and
Additional file 1: Figure S2A). Gene set enrichment ana-
lysis (GSA) showed that genes differently expressed
between saliva and blood were significantly enriched for
genes coding for nucleotide transport and metabolism
(COG F) (Table 2), whereas genes differently expressed
between blood and CSF were just slightly enriched for
genes involved in posttranslational modification, protein
turnover and chaperones (COG O, OR = 2.7, FDR > 0.10)
(Fig. 2a). GSA further showed significant differences also
in the directionality of gene expression changes (Fig. 2b).
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Fig. 1 (See legend on next page.)
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The 173 genes that showed higher expression levels in sal-
iva compared to blood were enriched for genes involved
in energy metabolism and conversion (COG C), posttrans-
lational modification, protein turnover and chaperones
(COG O) and cell envelope and outer membrane biogen-
esis (COG M). However, genes that were more highly
expressed in blood than in saliva and CSF, respectively,
were significantly enriched predominantly for genes cod-
ing for proteins without any COG functional annotation
so far, suggesting that our knowledge about the mecha-
nisms employed by meningococci to survive in human
blood are still quite limited.
Both strains differ in the expression of over 500 genes in
a condition and strain dependent manner
Based on the genome comparisons we further selected a
sub-set of 1450 single-copy orthologous genes for cross-
strain gene expression comparisons. Of these, 523 were
expressed and/or regulated at significantly different
levels between both strains (Additional file 1: Figure S2A
and Fig. 1b, c). Notably, proteins differently expressed in
at least one ex vivo condition were not significantly
more variable between both strains as indicated by their
BSRPs than proteins that were not (BSRPconstant = 0.993
vs. BSRPdiff. expressed = 0.995, Wilcoxon test, p > 0.05),
(See figure on previous page.)
Fig. 1 Genes significantly differently expressed and/or regulated in cross-condition and/or cross-strain comparisons. a Venn diagram comparing
sets of genes in strain MC58 differently expressed between conditions as indicated. The total number of genes compared was 1987. b Venn
diagrams comparing sets of genes differently expressed between strains as indicated with each diagram. The total number of genes compared in
each panel was 1450. c Heatmap depicting cross-condition and cross-strain gene expression differences and hierarchical clustering of significantly
differently expressed genes. Average linkage clustering based on the Spearman rank correlation of all 828 genes significantly differently expressed
and/or regulated in at least one cross-condition and/or cross-strain comparison (FDR < 0.05). Grey lines correspond to genes that were absent in the
α522 genome sequence and therefore excluded from the cross-strain comparisons
Table 2 Significantly enriched COG functional categories in cross-condition and cross-strain comparisons
Non-directional(a) Directional(b)
COG functional category OR(c) FDR(d) OR(e) FDR(d)
MC58 cross-condition comparisons
Saliva ↔ Blood
Nucleotide transport and metabolism (COG F) 2.66 0.044 n.s. n.s.
Energy metabolism and conversion (COG C) n.s. n.s. 0.18 0.024
Cell wall/membrane/envelope biogenesis (COG M) n.s. n.s. 0.31 0.020
Posttranslational modification, protein turnover, chaperones (COG O) n.s. n.s. 0.13 0.023
Not in COG n.s. n.s. 6.53 <0.001
Blood ↔ CSF
Not in COG n.s. n.s. 0.06 <0.001
MC58 versus α522 cross-strain comparisons
Blood
Energy metabolism and conversion (COG C) 2.25 0.008 11.6 <0.001
Cell wall/membrane/envelope biogenesis (COG M) n.s. n.s. 0.19 <0.001
Saliva ↔ Blood
Energy metabolism and conversion (COG C) 2.99 <0.001 >5.33 <0.001
Translation, ribosomal structure and biogenesis (COG J) n.s. n.s. 0.04 <0.001
Cell wall/membrane/envelope biogenesis (COG M) n.s. n.s. 0.09 0.003
Blood ↔ CSF
Energy metabolism and conversion (COG C) 3.27 <0.001 n.s. n.s.
(a) Comparison of differently versus non-differently expressed genes to identify COG categories that are affected by differential expression in general
(b) Comparison of differentially expressed genes to identify COG categories that are significantly affected by regulation in a distinct direction (gene
expression asymmetry)
(c) Odds ratios based on Fisher’s exact test. Values greater than 1 indicate that significantly differentially expressed genes are enriched for genes from the
corresponding COG functional class
(d) False discovery rate based on p-values from Fisher’s exact test and the Benjamini-Hochberg multiple testing correction with a significance cut-off of FDR < 0.05
(e) For cross-condition comparisons, values greater than 1 indicate that genes highly expressed in blood were enriched for the respective COG category. In cross-
strain comparisons, values greater than 1 indicate that the respective COG category is significantly highly expressed or upregulated in strain MC58
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confirming that there was no significant sequence bias
in the expression data.
Of all the 728 genes that showed cross-condition and/
or cross-strain expression differences 345 were differ-
ently expressed only in cross-strain and 205 only in
cross-condition comparisons, respectively, and the over-
lap between cross-condition and cross-strain expression
comparisons was thus surprisingly small (Fig. 1b). The
total number of significantly differently expressed genes
between both strains was small in rich medium (PPM+)
(n = 55) and CSF (n = 59) and not significantly greater
than the number expected by chance (FDR < 0.05, bino-
mial test, p > 0.10), and there were only 8 and 12 genes
that showed significant expression level differences
between both strains exclusively in CSF and PPM+,
respectively. The number of differently expressed
genes was significantly higher for saliva (n = 93) and
blood (n = 440) (binomial test, p < 0.01) than expected
by chance (FDR > 0.05), although both strains were
not able to grow in saliva. This further suggests that
gene expression differences were not due to growth
rate differences but were specific responses of both
strains to these two ex vivo conditions. In line with
this hypothesis, the transcriptomes differed signifi-
cantly among both strains in response to the ex vivo
condition tested (Pearson’s χ2 test, p < 10-15). Of note,
the pattern of transcriptionally activated genes upon
transition from saliva to blood was opposite to the
pattern of transcriptionally activated genes upon tran-
sition from blood to CSF (Figs. 1b and 2b), indicating
that transcriptional changes are likely in response to
components present in human blood but neither in
saliva nor CSF. Since these two ex vivo compounds
were both free of any phagocytic cells, differences in
transcriptional responses in both strains might be
triggered by blood phagocytes.
Cross-strain gene expression differences in saliva
comprise numerous stress response genes
A total of 93 genes were differently expressed between
both strains in saliva, with a slight yet not significant en-
richment of genes involved in anorganic ion transport
and metabolism (n = 10, COG P) (Fig. 2a). Functionally,
around one third coded each for poorly characterized
proteins (n = 27, COGs R, S and X), proteins involved in
cellular processes (n = 34) or proteins involved in
Fig. 2 Gene set enrichment analysis of differently expressed genes. a Non-directional comparison of significantly differently expressed gene
sets according to the COG functional classification scheme for cross-condition and cross-strain comparisons, respectively, indicating significantly
overrepresented functional categories among the significantly differently expressed genes. b Directional comparison of significantly differently
expressed gene sets according to the COG functional classification scheme for cross-condition and cross-strain comparisons, indicating significant gene
expression asymmetries. In both panels, the heat map depicts significantly enriched COG functional categories in red coloring. The kind of comparison
(cross-condition for strain MC58 and cross-strain for each condition) is indicated for each column of the heat maps, and the corresponding FDRs
are color coded and given in the respective inserts. The associated tree is based on average linkage clustering of the functional categories using
the Spearman rank correlation coefficient
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metabolism or information storage and processing.
Among the 55 genes highly expressed in strain α522
were, amongst others, seven for anorganic ion transport
and metabolism proteins (COG P) including a putative
multidrug resistance protein (NMB0393), the lactoferrin-
binding protein A (LbpA) and the putative ammonium
transporter AmtB, as well as six genes involved in cell
envelope biogenesis (COG M) including genes for the two
sialic acid capsule biosynthesis proteins SynX/SiaA/CssA
and SiaB/CssB. Genes involved in translation and riboso-
mal biogenesis (COG J) comprised the single largest group
(n = 10) among the genes that were in turn highly
expressed in strain MC58 in saliva, next to genes in amino
acid transport and metabolism (n = 4, COG E) and cell
envelope biogenesis (n = 4, COG M). Since both strains
were not able to grow in human saliva these gene expres-
sion differences likely reflect differences in the stress re-
sponse between both strains when exposed to this hostile
environment.
Both strains differed in the expression of virulence-
associated genes involved in the pathogenesis of IMD
Numerous genes involved in the interaction of meningo-
cocci with its human host have so far been studied in
order to understand the genetic and mechanistic basis of
meningococcal virulence, i.e. host damage, and were
consequently of special interest. Accordingly, of the
102 virulence-associated genes used for cross-strain
comparisons (compiled from ref. [21, 38–40])
(Additional file 2: S1), 48 were differently expressed
and/or regulated among both strains under at least
one of the ex vivo conditions tested which is signifi-
cantly more than in the cross-condition comparisons
for strain MC58 (2-sample test for equality of pro-
portions, p < 0.01) (Table 3). In addition, genes differ-
ently expressed and/or regulated between both
strains in at least one cross-strain comparison were
significantly enriched for virulence-associated genes
(OR = 1.55, p < 0.05), and the expression profiles were
significantly different between virulence-associated
and not virulence-associated genes (Pearson’s χ2 test,
p < 10−15). Of the 38 virulence-associated genes that
were differently expressed between both strains in
blood, 16 were highly expressed in α522 and com-
prised genes involved in cell envelope biogenesis and
in particular genes for capsule and LOS biosynthesis.
LOS was shown to be the dominant molecule in
meningococci inducing organ inflammation in human
patients [48], and differences in LOS biosynthesis
might therefore have an immediate impact on the
extent of host damage caused by both strains. In
turn, genes involved in type IV pilus biosynthesis
iron homeostasis, the stress response genes as well as
genes encoding adhesins such as Opc or the
hemagglutinin/hemolysin-related protein TpsA3 or NspA
[49] were all highly expressed in MC58. Besides Opc, we
could at best detect only very small expression level
differences for other recently introduced vaccine antigens
that were conserved in both strains (NMB1030 and
NMB2091).
Likewise, of the 37 genes that have been described so
far as being involved in neutrophil interactions in
Neisseria and which were part of the gene expression
comparisons [38], 15 were differently expressed between
both strains in blood (Additional file 2: S1). Genes differ-
ently expressed between both strains were therefore
significantly enriched for neutrophil response genes
(OR = 2.9, p < 0.01). These included a number of
virulence-associated genes like capsule synthesis genes
or genes coding for efflux pump components
(Table 3), as well as genes not so far associated with
meningococcal virulence like the DNA damage repair
genes uvrA and uvrB. This finding indicates that neu-
trophils might have an important role in shaping the
meningococcal transcriptional response to human
blood.
Of note, aniA (also annotated as panI) encoding nitrite
reductase and norB coding for NO reductase [50]
showed the largest blood-specific expression differences
between both strains (8- to 32-fold) and were among the
highest expressed genes in MC58 as was also confirmed
by qRT-PCR (Additional file 1: Figure S3). The gene
products AniA and NorB constitute a pathway that
enables the organism to grow under conditions of low
oxygen in the presence of nitrite. Amongst others, men-
ingococcal derived NO was recently shown to play an
essential role in the pathophysiology of septicemic men-
ingococcal infection in humans by inhibiting platelet
aggregation [51] and modifying the release of cytokines
and chemokines by human macrophages [52].
Therefore, a number of virulence-associated genes
with an also experimentally established role in the
pathogenesis of IMD like aniA or LOS biosynthesis
genes were differently expressed in both strains particu-
larly in human blood.
Transcriptomic differences between both strains
associated with the transition from saliva to blood are
enriched for metabolic, information processing and cell
envelope biogenesis genes
Overall, the number of differently expressed genes be-
tween both strains was highest in blood (n = 440), and
also the number of genes differently regulated between
both strains between two conditions was highest be-
tween saliva and blood (n = 245) (Fig. 1). Both gene sets
were functionally enriched for genes required for energy
production and conversion (COG C) (Fig. 2a, Table 2).
These data thus clearly demonstrate differences in the
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environment-dependent gene-expression regulation be-
tween both strains. The 196 genes highly expressed in
strain α522 in human blood were significantly enriched
for genes involved in cell wall/membrane biogenesis
(COG M) (Fig. 2b, Table 2), including LOS and peptido-
glycan biosynthesis genes like murB, murD, murE and
ddl. In contrast, the 244 genes highly expressed in strain
MC58 were significantly enriched for metabolic genes
(COG C) including genes for oxidative phosphorylation
(nqrBDF) and nitrogen respiration such as aniA and
norB described above.
With respect to differences in the direction of gene ex-
pression regulation in both strains, genes required for
energy production and conversion (COG C) were also
strongly upregulated in strain MC58 between saliva and
blood, whereas genes for cell envelope biogenesis (COG
M) and translation (COG J) were in turn strongly upreg-
ulated in strain α522.
Based on differences in the directionality of gene ex-
pression levels and regulation (Fig. 2b), the functional
categories COG E, C and M form a cluster of co-
regulated genes which is part of a larger cluster includ-
ing also the functional categories COG J, COG K and
COG L. This finding suggests a regulatory link between
metabolism, the biosynthesis of the cell envelope, and
genes for the gene expression machinery which is differ-
ently activated in both strains particularly in human
blood.
Integrative network analysis of differently expressed
genes identifies subnetworks of co-regulated genes
In order to identify differentially expressed functional
subnetworks, we combined the transcriptomic with
protein-protein interaction (PPI) network data of strain
MC58 as deposited in the STRING database and used
an algorithm which optimally identifies responsive
subnetworks [53, 54]. This integrative network analysis
revealed a densly connected subnetwork comprising
mainly genes that are highly expressed in strain MC58
in blood (30/35 genes, 2-sample test for equality of pro-
portions, p < 10-5) involved particularly in energy and
carbohydrate metabolism (Fig. 3a). This subnetwork
comprised genes of the tricarboxylic acid (TCA) cycle
(aceF, sdhC, sucA, sucC, sucD), for the metabolism of
pyruvate (accB), glycine (gcvH, gcvT), leucine (leuA,
leuB) and fatty acids (accB, acp-2, fabD, fabH). The sec-
ond subnetwork contained significantly more genes
highly expressed in strain α522 (62/128 genes, p < 10-4)
coding for a significantly different array of cellular func-
tions (Pearson’s χ2 test, p < 10-6). It comprised genes in-
volved in the biosynthesis of the capsule (siaA/synX,
siaB), peptidoglycan (murB, murD, murE), and LOS
(kdtA, lpxB), respectively, as well as genes for trafficking,
secretion and vesicular transport (dprA, ffh) or
information storage and processing including in particular
translation and ribosomal biogenesis genes (rpmE, map).
A few genes in this second subnetwork were highly
expressed in MC58 yet and included genes for glycolysis
(eno, galM, gapA-2, glk, pgm), the genes for the Na+-trans-
locating NADH-quinone reductase subunit B, D and F
(nqrB, nqrD, nqrF) along with virulence-associated genes
mentioned above like dsbA-1, pilG, pilT-2, sodC (Table 3).
Transcriptomic differences in both strains in blood were
thus organized in two subnetworks consisting mainly of
genes that were either highly expressed in α522 or in
MC58 and that coded for different biological functions.
Along with these cross-strain differences in the direc-
tionality of gene expression levels also cross-strain differ-
ences in the directionality of gene regulation between
saliva and blood were organized in two functionally dif-
fering subnetworks (Pearson’s χ2 test, p < 10-6) (Fig. 3b).
The first subnetwork consisted almost exclusively of
genes found to be upregulated in MC58 in blood com-
pared to saliva (47/59 genes, p < 0.001), and over 70% of
the genes in this subnetwork code for metabolic func-
tions compared to only 24% in the other subnetwork
(OR = 7.25, p < 0.001). It comprised genes for TCA cycle
enzymes (icd, lpdA1, sdhB, sucA, sucC, sucD), for 2-
oxocarboxylic acid metabolism (asd, leuB), oxidative
phosphorylation (petA, fixO, nuoA), fatty acid metabol-
ism (accB, acp-2, fabG, fabH), for thioredoxin-fold pro-
teins (kat, NMB0946, NMB1366, sodC) required for
oxidative stress response as well as the oxidoreductase
genes nqrB, nqrD, nqrF and aniA, the latter playing a
major role in the pathogenesis of IMD as described
above. The second subnetwork consisted of genes that
were strongly upregulated in strain α522 in blood com-
pared to saliva (15/25 genes, p < 10−7) and included pre-
dominantly genes involved in information storage and
processing and in particular for the translation machin-
ery (hisS, prmA, map, NMB0347, NMB0348).
In line with the GSA results, integrative network ana-
lysis thus indicated that in contrast to strain α522 strain
MC58 allocates transcriptional resources predominantly
in the expression of metabolic genes in human blood.
Elementary mode analysis of blood transcriptomic data
indicate compensatory flux differences between both
strains particularly in energy, glutamine and cysteine
metabolism
In order to assess the possible impact of the transcrip-
tomic differences on metabolism in blood in more detail,
we reconstructed a condensed metabolic network based
on the Nmb_iTM560 model for strain MC58 [55] com-
prising 123 enzymes (complexes) and 129 metabolites.
The 54 elementary metabolic modes and pathways as
identified by elementary mode analysis [56] are given in
the Additional file 3: S2.
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Fig. 3 (See legend on next page.)
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Computation of metabolic fluxes [57] based on the
observed growth rates of both strains in human blood
(Table 1), the corresponding gene expression data
(Additional file 2: S1) and the average composition of
human blood as taken from [58] showed that the flux
activities in MC58 were 25-50% higher than in α522
with major differences in the metabolism of some
amino acids (flux ratios higher than 6 or lower than
0.72) (Fig. 4a). Of note, one flux mode (EM 05) dis-
played an opposite direction between MC58 and
α522, indicating that α522 uses a large amount of
external glutamine (Gln) from human blood to pro-
duce gutamate (Glu).
For more detailed information about differences in
important biochemical pathways, we converted the flux
activities into enzyme and enzyme complex activities,
respectively. The major differences are given in Table 4
and Fig. 4b. Only very few fluxes were slightly stronger
in α522 such as R049, R050 and R132 which are all in-
volved in sulfur metabolism. On the other hand, there
were numerous reactions that were even more than ten-
fold stronger in MC58 than in α522 such as the acetate
synthesis reactions R117, R118 and R155 suggesting that
MC58 compared to α522 may accumulate acetate as
intermediate metabolite in this environment. In menin-
gococci, such metabolic stimulation has been shown to
result from the consumption of lactate which in the
presence of glucose is used as a source of additional en-
ergy [59]. Of note, lactate is a by-product of neutrophil
glycolysis and enhances bacterial consumption of mo-
lecular oxygen, which depletes the substrate for neutro-
phil NADPH oxidase and thus blunts its oxidative burst
[38]. Since both strains have almost identical growth
rates in human blood (Table 1) MC58 probably requires
this additional metabolic energy for other, not growth
related processes such as, e.g., defense against the neu-
trophil oxidative burst. Other reactions that were par-
ticularly stronger in MC58 included R001, R002 and
R015 leading from phosphoenolpyruvate (PEP) to α-
ketoglutarate (AKG) as well as some reactions involved
in amino acid metabolism like R052 and R053 resulting
in the synthesis of serine (Ser) from Glu and glycine
(Gly), respectively, or R056, R062 and R063 resulting in
the synthesis of leucine (Leu), phenylalanine (Phe) and
tyrosine (Tyr) from Glu, respectively. Since the reactions
R052, R056, R062 and R063 are all transamination reac-
tions resulting in the consumption of Glu and concomi-
tant synthesis of AKG, these findings further suggest
that MC58 and α522 might differ in their intracellular
levels of Glu and AKG in human blood. Finally, reac-
tions R030 and R031 have opposite directions in both
strains in human blood, which indicates that α522 relies
mostly on Gln to produce Glu with some Glu being fur-
ther converted into AKG, whereas MC58 is capable to
produce enough Glu from the TCA cycle and convert it
further to Gln. Likewise, also reaction R047 which is the
production of cysteine (Cys) from serine (Ser) has an op-
posite direction in both strains in human blood, and
α522 consequently seems to rely on external Cys to pro-
duce Ser whereas MC58 is capable of producing Cys
from Ser.
Strain α522 differs from strain MC58 in Gln and Cys
auxotrophy in vitro
In order to experimentally validate the transcriptomic
results with respect to possible differences in Gln and
Cys metabolism, we assessed the growth of both strains
in MMM supplemented with different amino acids as
well as PPM+ (Fig. 5a). Whereas both strains were
equally able to grow in PPM+ and MMM supplemented
with all 20 proteinogenic amino acids at milimolar con-
centrations, strain α522 was not able to grow in MMM
without amino acids. In addition to glucose or lactose as
carbon source (data not shown) it requires Cys and Gln
for growth (Additional file 1: Figure S4). Contrary to
α522, the growth of MC58 was slightly suppressed by
these two amino acids. The ability of MC58 but not
α522 to grow in the absence of Cys and Gln indicates
strain specific differences in the respective metabolic
pathways, and the requirement of some meningococcal
strains for Cys and its growth inhibiting effect on others
has already been reported [60]. In parallel with these
(See figure on previous page.)
Fig. 3 Analysis of gene expression data based on protein-protein interaction networks. a Integrative network analysis of differently expressed
genes between strain MC58 and α522 in human whole blood based on the STRING protein-protein interaction network for strain MC58 (FDR < 10
−9). A subnetwork that consists predominantly (30/35) of genes that were expressed at higher levels in MC58 than in α522 and that code for
metabolic genes and in particular for genes involved in energy production and conversion (85%) is shaded in orange. The remaining part of the
network comprising 128 protein-coding genes is shaded in light blue. b Integrative network analysis of gene regulation differences between both
strains upon transition from saliva to blood (FDR < 10−7). The two modules consisting predominantly of genes either upregulated in α522 (15/25)
or MC58 (47/59) upon transition from saliva to blood are shaded in green and orange, respectively. Only 21% of the genes in the left subnetwork
consisting mainly of genes that were upregulated in α522 code for proteins involved in (energy) metabolism compared to over 66% of the genes
that were upregulated in MC58 upon transition from saliva to blood. For each gene, the respective expression differences between conditions
and strains, respectively, are color coded and indicated in each panel. White boxes indicate genes that were not differently expressed but are
part of a subnetwork as identified by the integrative network analysis. Pie charts next to the sub-networks in each panel show the distribution of
proteins in the respective subnetwork over the different COG functional classes
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phenotypic differences, genome comparisons revealed
also striking differences in Cys and Gln biosynthesis
genes that might contribute to the phenotypic finding,
although the repertoire of enzymes required for the
biosynthesis of amino acids is otherwise highly
conserved in both genomes. In addition to the duplica-
tion of cysGHDNJI genes in MC58 (Additional file 1:
Figure S2A), these include large sequence differences in
the phosphoadenosine phosphosulfate reductase CysH
and the glutamate-ammonia-ligase adenylyltransferase
GlnE which are among the least conserved genes
involved in the biosynthesis of amino acids (Additional
file 1: Figure S2C). CysH is required for the reduction of
sulfate into hydrogen sulfide and thus for sulfur acquisi-
tion in N. meningitidis [61], and GlnE is a key regulatory
enzyme in nitrogen assimilation in E. coli [62]. Further-
more, the intergenic region between purL and glnB
differs in both strains due to the insertion of coding
sequence in strain α522 upstream of glnB resulting in en-
tirely different glnB promoter regions (Additional file 1:
Figure S2D). Along with GlnE GlnB is involved in the
regulation of nitrogen assimilation in E. coli via affecting
the activity of GlnA, an enzyme that lies at the heart of
the nitrogen assimilation network. GlnA is involved in the
complex regulation of the interconversion of Glu to Gln
in response to the intracellular concentration of ammo-
nium, Glu, the Gln/AKG ratio, the redox (NADPH) and
the free energy state of the cell [62]. Sequence variation at
these loci is therefore likely to have pleiotropic effects, and
a detailed experimental analysis of the biochemical
(See figure on previous page.)
Fig. 4 Analysis of gene expression data based on a metabolic model for strain MC58. a Comparison of elementary mode activities in MC58 and
α522. The histogram depicts differences in the elementary mode activities (ordinate) for each of the elementary metabolic modes (abscissa) as
defined in the Additional file 3: S2 for strain MC58 (red) and α522 (blue) based on gene expression data in human blood. b Inferred differences in
metabolic fluxes between strain MC58 and strain α522 in blood based on a metabolic model for strain MC58. Internal metabolites which are
considered to have balanced concentrations are given by dark green spheres, external metabolites which are allowed to accumulate or to be
consumed by green cones, and reactions together with their corresponding numbers as light green boxes. The reactions for all reaction numbers
are given in the Additional file 3: S2. Arrows connect reaction with metabolites. Red coloring indicates higher fluxes in MC58 compared to strain
α522, whereas blue colouring indicates that the flux is slightly enhanced in α522. Asterisks along with pink colouring indicate that the reaction
has an opposite direction in both strains
Table 4 Inferred reaction activity differences between MC58 and α522 in human blood based on gene cross-strain expression
differences
Reaction Chemical Equation Enzyme(s) Ratio(a)
R030 AKG + NADPH + NH3 = GLU + NADP Glutamate dehydrogenase −14.85
R031 ATP + GLU + NH3 = ADP + GLN Glutamine synthetase −3.03
R047 AcCoA + H2S + SER = ACE + CYS + CoA Serine acetyltransferase + cysteine synthase −2.32
R001 AcCoA + OXA = CIT + CoA Citrate-synthase 13.86
R002 NADP + CIT = CO2 + NADPH + AKG Aconitase 13.86
R015 CO2 + PEP = OXA Phosphoenolpyruvate carboxylase 11.90
R052 3PG + GLU + NAD = AKG + NADH + SER Serine synthesis: 3PG dehydrogenase + pserine aminotransferase +
pserine phosphatase (SerA+ SerB + SerC)
7.63
R053 SER = GLY Serine hydroxymethyltransferase 7.45
R056 AcCoA + GLU + IVA + NAD = AKG + CO2 +
CoA + LEU + NADH
Leucine synthesis: isopropylmatate synthase + isopropylmalate
dehydratase + isopropylmalate dehydrogenase + aminotransferase
(LeuA + LeuB + LeuC + LeuD)
6.78
R061 CHOR = PRE Chorismate mutase 12.58
R062 GLU + PRE = AKG + CO2 + PHE Aminotransferase + phenyalanine synthesis 12.58
R063 GLU + NAD + PRE = AKG + CO2 + NADH + TYR Aminotransferase + tyrosine synthesis 12.58
R117 ACA + NADH = ETH + NAD Alcohol dehydrogenase 14.74
R118 ACE + NADH = ACA + NAD Aldehyde dehydrogenase 14.74
R155 ACE = ACE_ext + H_ext Acetate transporter 11.50
R049 O2 + THS = 2 SO3 Thiosulfate reductase 0.61
R050 3 NADPH + SO3 = H2S + 3 NADP Sulfite reductase 0.71
R132 H2S = HS
−_ext + H_ext Sulfur transporter 0.45
(a) Ratio of the reaction activity in MC58 divided by the reaction activity in α522. A ratio larger than one indicates that the reaction has a higher activity in MC58,
and a negative ratio that the reaction occurs in opposite directions both strains
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consequences of these genetic differences is subject to on-
going work.
Expression changes in numerous regulatory genes are
likely compensatory
The large transcriptome differences observed particu-
larly in blood could be caused by differences in regula-
tory elements acting either in cis or in trans, or be
compensatory to ensure cellular homeostasis. Among
the 1757 orthologous proteins those involved in gene
expression regulation (COG K and T) were no more dif-
ferent between both strains than proteins involved in
other functions (BSRPCOGK/T = 0.9944 vs. BSRPother =
0.9936, Wilcoxon test, p > 0.05). Also the 200 bp
upstream regions were not less conserved than the
downstream orthologous genes (BSRN5’-UTR = 0.9823 vs.
BSRNCDS = 0.9671, Wilcoxon test, p > 0.05). Of the 1450
single-copy orthologous genes used for transcriptomic
comparisons 30 differed in the presence of putative
mobile genetic elements within their 200 bp upstream
regions (Additional file 2: S1). These comprised various
so called minimal mobile elements [63, 64] as well Correia
repeats and Correia repeat enclosed elements which have
previously been shown to affect gene expression in a polar
manner [65–67]. However, this class of genes was not
enriched for genes differently expressed in at least one
ex vivo condition. Although genetic differences in gene
regulatory elements might contribute to the transcrip-
tomic differences these data do not provide evidence
yet that they are the sole reason of the large cross-
strain expression differences observed particularly in
human blood. They might rather orchestrate different
compensatory gene expression adaptations in both
strains in response to differences in the interaction of
both strains with human blood components.
Both strains activate different sets of regulatory genes in
response to human blood
Of the 41 genes with significant expression differences
in cross-condition or cross-strain comparisons involved
in signal transduction or transcription (COG K or T), 18
showed significant expression level differences between
both strains in blood (Table 5). The eight regulatory
genes that were highly expressed in MC58 specifically in
blood included in particular cstA annotated as carbon
starvation protein A, NMB0398 coding for an ArsR
family transcriptional regulator, relA encoding the
guanosine 3'-(tri)diphosphate 5-'diphosphate ((p)ppGpp)
synthetase of the stringent response pathway, as well as
misR (NMB0595) coding for a PhoP-family response
regulator of a two component signal transduction sys-
tem. Of note, 64 genes of the 440 genes differently
expressed in blood belong to the MisR regulon [33], and
MisR was shown to be involved in the oxidative stress
response in meningococci [34], required for colonization
of host cells [68] and meningococcal survival in mice
[69]. In addition, 22 differently expressed genes which
are part of the Fur regulon [70] were almost all highly
expressed in MC58. Since Fur senses cellular iron
concentrations and since iron in general acts as a co-
repressor, these data indicate that strain MC58 might
experience more pronounced iron starvation in blood
compared to strain α522. Likewise, another 45 genes
are known to be regulated by FNR [32], the master
regulator involved in the adaptation to oxygen-limited
conditions, of which the majority (29) were also
highly expressed in MC58.
In turn, the ten regulatory genes highly expressed in
α522 included NMB0282 encoding a exoribonuclease
and rpoE (NMB2144) which codes for the alternative
sigma factor E (σE) and in N. gonorrhoeae is activated in
response to oxidative stress [71]. Since phagocytic cells
are a major source of reactive oxygen species and
were present only in the blood assay, these data fur-
ther suggests that σE might be involved in meningo-
coccal interaction with human phagocytes. In line
with previous findings that the expression of aniA
and norB are under the negative control of σE [72],
both strains also showed significantly different expres-
sion levels of aniA and norB especially in blood as
mentioned above (Additional file 1: Figure S3). Along
with the finding that nitric oxide (NO) generated by
AniA inhibits platelet aggregation [51] this observa-
tion provides a direct link between the oxidative
stress response and the pathophysiology of IMD.
These data indicate that the complex gene expression
differences between MC58 and α522 specifically in blood
are caused by the activation of different sets of regulatory
genes including MisR, Fur, FNR, RelA and σE. In contrast
to the expression of rpoE [72] and misR [33, 34] which in
both cases was found to be auto regulated, Fur and FNR
did not differ in their expression between both strains,
(See figure on previous page.)
Fig. 5 Growth phenotypes of N. meningitidis MC58 and α522 wild-type and mutant strains. a In vitro growth phenotypes. Growth as quantified
by the optical density (OD600nm) is given on the ordinate and the time in hours on the abscissa. b Ex vivo growth phenotypes. The number of
colony forming units for each time point (N(t)) relative to the initial number (N(0)) is given on the ordinate and the time in minutes on the
abscissa. For each strain and condition the respective growth curves are coded as indicated in the insert in each panel, and the genotypes of
the respective strains compared are shown along with the corresponding growth curves. In each experiment rich medium (PPM+) was used as
growth control. The arrow at the top of panel b indicates the time when total RNA was extracted for microarray analysis
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suggesting strain-dependent differences in the post-
transcriptional activation of these regulators especially in
blood.
Differences in promoter regions demonstrate an
important role for the stringent response and Hfq
mediated differences in gene expression regulation
among both strains in blood
Although sequence analyses of the 200 bp upstream re-
gions of the 524 genes that were differently expressed
between both strains in cross-strain comparisons failed
to identify any consistent sequence differences or over-
represented bona fide TF binding sites for any of the
cross-strain comparisons, the analysis of GC content
variation yet revealed a 6 bp region immediately up-
stream of the predicted ribosome binding site (RBS) hav-
ing a significantly lower GC content in genes that were
expressed at higher levels in MC58 than in α522 in
blood (GCMC58 = 37% vs. GCα522 = 42%, Wilcoxon test,
p < 0.01) (Fig. 6). At the mRNA level, such AU-rich ele-
ments next to the RBS are often targets for the Hfq-
mediated binding of small non-coding RNAs which thus
post-transcriptionally regulate the degradation and/or
translation efficiency of the corresponding mRNA [73].
In strain MC58, the RNA chaperone Hfq was already
shown to be involved in the regulation of amino acid
and energy metabolism, the oxidative stress response
and required for survival in human blood [74]. The
comparison of the differently expressed genes showed
that of the 18 genes that are part of the Hfq regulon
and that were included in this study, 9 were differ-
ently expressed in both strains, all higher in MC58.
Therefore, these data suggest that Hfq contributes to
gene regulation differences between both strains in
blood.
Furthermore, genes differently expressed between both
strains in blood had also significant GC content differ-
ences in a 10 bp region 40 bp upstream of the predicted
RBS (GCMC58 = 44% vs. GCα522 = 48%, Wilcoxon test, p
< 0.05) (Fig. 6), and there was a negative correlation be-
tween expression differences in blood and the deviation
from the average genomic GC content (Spearman’s rank
correlation ρ = - 0.12, p = 0.01). Since the average length
of 5’-UTRs in Neisseria was shown to be between 40
and 50 bp [75] this region corresponds to the transcrip-
tional start site. The length of this region, its pattern of
GC content variation and its location close to the
presumed transcriptional start site are hallmark features
of so called discriminator regions [76] which in γ-
proteobacteria determine whether the adjacent gene is
activated or repressed during the stringent response.
Accordingly, of the 440 genes differently expressed be-
tween both strains in human blood, 117 have a discrim-
inator GC content higher than the genome-wide average
of 50% and were highly expressed in α522, and 131
genes with a discriminator GC content lower than the
average were highly expressed in MC58 (OR = 1.69, p <
0.01). Together, these genes account for 56% of all genes
differently expressed in blood. Since activated targets
typically have an AT-rich discriminator whereas re-
pressed targets have a GC-rich discriminator, these data
along with the higher expression of relA in MC58 indi-
cate that in blood the stringent response pathway is
comparatively more activated in MC58 than in α522.
Fig. 6 GC content variation in potential promoter regions based on the MC58 genome sequence. a Scatter plot of the GC content variation
averaged over a 5-bp sliding window within 100 bp upstream regions for genes highly expressed in MC58 (red and yellow lines) or α522 (light
and dark blue lines) in human blood. The black line gives the GC content of the respective upstream regions for genes not differently expressed.
Regulatory regions are indicated at the top of the panel based on the average length of 5’-untranslated regions in N. gonorrhoeae [75]. The insert
gives the number of genes in each gene set. b Box-and-whiskers plot depicting differences in the mean GC content of the putative discriminator
(left) and Hfq-binding regions (right) between genes highly expressed in MC58 (red) or α522 (blue) in human blood as depicted in panel (a). The
line within each box gives the median and the upper and lower margins the upper and the lower quartile, respectively. The whiskers denote the
highest and the lowest values, respectively, and the open circles outliers. *: p < 0.05, **: p < 0.01 (Wilcoxon test)
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Genes highly expressed in MC58 and with a low GC
discriminator region were predominantly involved in
energy production and conversion (COG C, OR = 4.79,
p < 0.05) and comprised genes involved in carbohydrate
(pykA, mapA, pgm, rpe, suhB) and energy metabolism
(hprA, nuoA, nuoG, nuoL, nqrF, sdhC, lpdA1, pntA, leuB,
fumC, fixO, aldA, etfA), in aerobic energy generation
(sdhC, ccoN (NMB1725), ccoO (NMB1724)), the genes
for cytochrome c4 (NMB1805) and c5 (NMB1677)) as
well genes required for the oxidative/nitrosative stress
responses (bfrAB, gltS, gshA, grx, sodC) along with sur-
face proteins like NspA, Lip and Laz. Genes highly
expressed in α522 and having a high GC discriminator
region were predominantly involved in cell envelope and
outer membrane biosynthesis (COG M, OR = 11.7, p <
0.001) and included genes for LOS (kdtA, lpxB) and pep-
tidoglycan biosynthesis (ftsW, murD, murE, ddl) as well
as regulatory genes including rpoE.
RelA and the stringent response pathway contribute to
meningococcal ex vivo fitness in a condition and strain
dependent manner
Although the stringent response pathway was already
shown to be crucial for virulence in a number of bacter-
ial pathogens [76], nothing is known about its contribu-
tion to meningococcal ex vivo or in vitro fitness so far.
Therefore, the observation that relA was differently
expressed between both strains exclusively in blood
along with the finding that genes differently expressed
between both strains in blood had significant GC con-
tent differences in their putative discriminator regions
prompted us to further assess the contribution of the
stringent response and in particulate of relA to meningo-
coccal fitness ex vivo.
The machinery of the stringent response pathway
comprises several enzymes involved in the turnover of
(p)ppGpp which is a signaling nucleotide that coordi-
nates a variety of cellular activities in response to
changes in nutritional abundance [76]. In E. coli, RelA is
activated upon amino acid starvation and together with
SpoT is able to catalyze pyrophosphoryl transfer from
ATP to GTP or GDP to synthesize (p)ppGpp. Together
with DnaK suppressor (DksA), (p)ppGpp directs tran-
scription initiation at particular gene promoters through
binding to the interface between the two RNA polymer-
ase subunits β’ and ω [77, 78]. In part, (p)ppGpp and
DksA act by promoting the interaction of RNA polymer-
ase with alternative σ-factors such as σE or σH. When
metabolic precursors are plentiful, SpoT instead de-
grades (p)ppGpp, and the vegetative σ-factor, σ70, directs
RNA polymerase to genes that are crucial for bacterial
replication. Whereas β’, ω, SpoT and DksA were identical
in both strains they differed in the coding sequences and
promoter region of RelA (Fig. 7a), and gene expression
analyses via qRT-PCR further confirmed particular large
and blood-specific cross-strain expression differences for
relA but not for spoT or dksA (Additional file 1: Figure S3).
To test whether these differences in the coding se-
quences of relA affected its catalytic activity we assessed
ppGpp levels in wild-type, ΔrelA::Kmr as well as
ΔrelA::Kmr ΔspoT::Cmr mutants in both strains during
growth in PPM+ medium. As can be seen in Additional
file 1: Figure S5A, both alleles were catalytically active
and the catalytic activity was affected by the bacterial
growth phase in a similar manner. Similar to the α522
wild-type strain, the MC58 ΔrelA::Kmr mutant could
further not grow in minimal medium, and in both gen-
etic backgrounds the addition of all 20 proteinogenic
amino acids could compensate for the loss of functional
RelA but not the addition of only Cys and/or Gln to
minimal medium (Fig. 5a). In addition, similar to E. coli
(p)ppGpp0 strains the growth defect in minimal medium
was less severe in meningococcal ΔrelA::Kmr ΔspoT::Cmr
double mutants. In support of the notion that (too) high
levels of (p)ppGpp might be toxic for the meningococcal
cell we could not obtain viable isogenic spoT single dele-
tion mutants, and a presumed spoT knock-out mutant
had a compensatory frame-shift mutation prior the cata-
lytic domain of relA resulting in reduced ppGpp levels
(Additional file 1: Figure S5B and C).
With respect to ex vivo fitness the deletion of relA had
no effect in MC58 on growth in saliva, blood or CSF
whereas the α522 ΔrelA::Kmr mutant was severely im-
paired exclusively in blood (Fig. 5b). The ex vivo fitness
defect was less severe in a α522 ΔrelA::Kmr ΔspoT::Cmr
double mutant. Unfortunately, since all attempts to
clone full-length relA and spoT, respectively, in N.
meningitidis for cis/trans complementation assays failed,
the possibility that the observed phenotypes are, at least
in part, caused by polar effects cannot be ruled out
entirely. However, as depicted in Additional file 1:
Figure S6, there are rho-independent transcriptional
terminators at the 3′ ends of the relA as well as the
spoT gene which have not been altered in the respect-
ive mutants. Furthermore, since the phenotype of the
ATRrelA mutants particularly in blood resembles the
phenotype of the relA mutants in both strains, and
since both are also different from the phenotype of
the grxB mutants, it seems rather unlikely that the
relA phenotype is due to a polar effect on grxB ex-
pression (and vice versa) and not due to the de-
creased (p)ppGpp levels (Additional file 1: Figure S5).
Together, these data show that that the stringent re-
sponse pathway is functional in both meningococcal
strains despite their different relA alleles. The deletion
of relA is conditional lethal and it is differently expressed
between both strains under virulence-mimicking condi-
tions in human blood. The effect of relA on ex vivo
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fitness is thus dependent on the environment and the
genetic background.
A non-coding mobile element affects meningococcal
fitness in a strain- and condition-dependent manner
In addition to differences in the relA coding sequences,
the intergenic region between relA and the upstream
grxB encoding the redox enzyme glutaredoxin differed
substantially in both strains due to the integration of an
AT-rich (ATR) repeat element in strain α522 (Fig. 7a).
ATR repeat elements occur 12 and 13 times in the
genomes of α522 and MC58, respectively, of which
only 10 have the same position in both genomes
(Fig. 7b). They have a conserved length of 181 bp
with ends forming a perfect 13–bp inverted repeat
and belong to a class of non-autonomous DNA trans-
posons also known as miniature inverted-repeat
transposable-elements (MITEs) [79].
ATRs are almost exclusively located in intergenic re-
gions in both genomes and are almost ten times more
frequently found in intergenic regions flanked by conver-
gently transcribed genes than expected by chance (Fish-
er’s exact test, OR = 9.64, p < 0.001). This indicates that
the location in potential promoter regions might be
under negative selection possibly due to adverse effects
on the expression of neighboring genes. As experimen-
tally determined by 5’-RACE, the −35 boxes of the relA
promoter differ between both strains due to the inser-
tion of ATRrelA in strain α522 between the −10 and −35
boxes (Fig. 7a). Furthermore, growth experiments dem-
onstrated that the fitness of an ATRrelA knock-out strain
was impaired only in α522 and only in human blood
thus resembling the phenotype of the relA deletion mu-
tant (Fig. 5b). In contrast to the deletion of ATRrelA or
relA, the effect of deleting the neighboring grxB gene
was condition- but not strain-dependent. These findings
thus suggest that via affecting the expression of relA, dif-
ferences in the binding of transcriptional regulators
might contribute to the observed epistatic effects of
ATRrelA on ex vivo fitness. The conditional essentiality
of grxB for ex vivo fitness further supports the hypothesis
that the oxidative stress response is required for blood
survival especially in human blood. In support of a
background- and condition-dependent effect of ATRrelA
on meningococcal fitness, we could not observe any
ex vivo fitness differences between the ATRrelA knock-in
mutant strain MC58 relAp::ATRrelA and the correspond-
ing MC58 wild-type strain.
Surprisingly, the integration of ATRrelA into the relA
promoter region abolished however the inhibitory effect
Fig. 7 Genomic distribution of ATRs and the relA locus in N. meningitidis. a The intergenic region between grxB and relA. The integration site of a
copy of an ATR repeat element upstream of relA (ATRrelA) in strain α522 is indicated with respect to the MC58 locus. The transcriptional start sites
as determined by 5’-RACE in both strains are indicated along with the deduced −35 and −10 boxes and the computationally predicted promoter
regions using PPP [117]. DR: direct repeat. b Alignment of both the MC58 (upper lane) and α522 (lower lane) genomes as visualized with the
Artemis comparison tool based on a BLASTN comparison. The linearized MC58 and α522 genomes are shown in the upper and lower panel as
gray bars, and regions syntenic in both genomes are connected via red and inverted regions via blue lines, respectively. The location of ATRs is
indicated by small arrows in each genome, and the relA region is highlighted in yellow
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of Cys and Gln on growth in MMM in strain MC58,
whereas the deletion of ATRrelA had no effect on the
in vitro growth of α522 (Fig. 5a). This suggests a link
between Cys and Gln metabolism and the stringent
response regulation in a yet to define epistatic manner.
Although the role of MITEs in meningococcal infection
biology has already been established [66] this is the first
time that a biological function has been shown for the
ATR class of MITEs in an infection process.
Discussion
It has recently been shown that transcriptional regula-
tion in prokaryotes is more flexible than the genetic
component of the organisms and that its complexity and
structure plays an important role in phenotypic adapta-
tion [11]. However, little is known so far about the sig-
nificance of regulatory evolution that might underlie
bacterial virulence. Accordingly, we used a hypothesis-
generating systems biological approach [25, 26] to ana-
lyse gene-expression differences between two meningo-
coccal strains from a hyperinvasive and a carriage clonal
complex, respectively, under infection-mimicking condi-
tions (Additional file 1: Figure S1).
Despite the substantial genetic differences between
both strains affecting surface antigens as well as meta-
bolic genes likely affecting Cys and Gln biosynthesis
(summarized in Fig. 8), both were surprisingly similar in
a variety of in vitro virulence assays and in their growth
behavior under infection mimicking conditions (Table 1
and Fig. 5). In particular, the finding that both strains
have the same fitness in human blood and CSF despite
the large differences in the disease/carriage ratios between
CC ST-32 and CC ST-35 strains further indicates that the
ability to grow under infection mimicking conditions
might be necessary but not sufficient for explaining the
invasive property of certain meningococcal lineages. Viru-
lence, i.e. host damage, might rather be related to the way
how meningococci accomplish growth in this environ-
ment. In line with this hypothesis, the large transcriptome
differences observed particularly in human blood (Fig. 1)
indicate that different transcriptional programs probably
compensate for the differences in the genetic backgrounds
of both strains in response to host components. This so
called phenotypic buffering is a general property of
complex gene-regulatory networks [25, 36].
Upon transition from commensal to invasive behavior
meningococci have to adapt to the accompanying large
environmental changes caused largely by differences in
nutritional and innate immunity in these different com-
partments. These comprise, e.g., differences in the pres-
ence of professional phagocytes or the availability and
concentration and of key nutrients such as amino acids
or iron [80–82]. Accordingly, it has already been shown
that the oxidative burst, which is one of the most
prominent effector mechanisms in human neutrophils,
is modulated by neisserial porins, and – although to a
lesser extent – also Opc has been described to be in-
volved in N. meningitidis – neutrophil interaction
(reviewed in [83]). The observed differences in the reper-
toire and/or expression of, e.g., Opc, PorA and PorB,
could lead to differences in the phagocytic uptake by
neutrophils and/or the activation of the oxidative burst
(Fig. 8). Phagocytosis and the activation of the neutro-
phil oxidative burst in turn exert nutritional and oxida-
tive/nitrosative stresses on the bacterial cell [38, 82]. The
resulting damage to the bacterial cell triggers bacterial
stress responses which in pathogenic bacteria have
already been considered as virulence factors. In particu-
lar, lactate, a by-product of neutrophil glycolysis, was
shown to enhance bacterial consumption of molecular
oxygen in the presence of glucose, which depletes the
substrate for neutrophil NADPH oxidase and thus
blunts its oxidative burst [38, 59, 84]. Accordingly, our
transcriptomic data analyses outlined above suggest a
particularly strong metabolic activation in strain MC58
in blood (Figs. 1, 2, 3 and 4). Another important compo-
nent in the oxidative/nitrosative stress responses in Neis-
seria is glutathione (GSH) [84]. It is synthesized from
Cys, Gln/Glu and Gly which are either taken up from
the environment or synthesized from precursors gener-
ated in the Entner–Doudoroff (ED) pathway and TCA
cycle, respectively [85] (Fig. 8). Via the GSH cycle, the
biosynthesis of Cys and Gln/Glu are thus linked to the
oxidative/nitrosative stress response [86]. We therefore
hypothesize that the observed sequence variations in
metabolic genes such as CysH, GlnE or GlnB involved in
Cys and Gln/Glu biosynthesis, respectively, lead to the
activation of compensatory transcriptional programs to
allow survival upon exposure to human blood phago-
cytes. Our data further indicate that relA contributes to
the homeostatic transcriptional response to nutritional
and oxidative/nitrosative stresses as it is required for
amino acid biosynthesis in N. meningitidis (Fig. 5). Con-
sequently, via variation in the GC content of the dis-
criminator regions, the accumulation of (p)ppGpp
during the stringent response might directly or indirectly
contribute to the adapative regulation of genes required
for energy metabolism, cell envelope biogenesis, transla-
tion and ribosome biogenesis and thus for large parts of
the meningococcal transcriptome (Figs. 6 and 8).
Furthermore, as the educt for Glu biosynthesis AKG
provides a potential metabolic link between energy me-
tabolism and the GSH cycle (Fig. 8) and was shown in
N. meningitidis to contribute to, amongst others, the
regulation of σE expression [87]. Since the expression of
aniA was in turn shown to be under the negative control
of σE [72], the finding that NO generated by AniA in-
hibits platelet aggregation [51] provides an exemplary
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Fig. 8 (See legend on next page.)
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link between oxidative stress, Glu/Gln metabolism and
the pathophysiology of meningococcal disease. In this
picture, virulence, i.e. host damage, occurs coincidentally
due to the transcriptional compensation of metabolic
deficiencies by including genes with an established role
in the pathogenesis of IMD. In consequence, meningo-
coccal virulence is a byproduct of global stress and
metabolic responses potentially triggered by human neu-
trophils and is dependent on the genetic background of
the invading strain. In line with the recently proposed
damage-response framework of microbial pathogenesis
[88], we further hypothesize that strain-dependent differ-
ences in the interaction of meningococci with human
neutrophils have a central role in explaining meningo-
coccal virulence differences. However, a better systems
biological understanding of the interaction of human
phagocytes with meningococcal cells under infection
relevant conditions has yet to be reached, and in
addition to transcription [89] many other layers such as
post-transcriptional modifications, allosteric regulation
[90] and non-coding small RNAs [91] are likely to play
an important role in metabolic regulation in
meningococci.
The phenotypic similarity of both strains under the
ex vivo conditions tested further indicate that most of
genotypic variation observed in the genomic compari-
sons (Additional file 1: Figure S2) is likely cryptic for se-
lection under conditions encountered by the species
during its commensal life-cycle, and only upon an envir-
onmental perturbation these genotypic differences do re-
sult in different phenotypes. In evolutionary genetics,
this so called cryptic genetic variation (CGV) describes
the part of the genetic diversity that has the potential to
affect the phenotype but that is not expressed under the
current genotypic or environmental conditions which
limits the opportunities for selection to act on the vari-
ation [35, 36]. However, under atypical conditions, rare
in the history of a population, CGV can generate pheno-
typic variation. Human blood is a condition that is nor-
mally not encountered by meningococci during its
commensal life cycle, and since bacteria replicating in
the bloodstream are not transmitted to new hosts it has
not been encountered by any ancestral meningococcal
strain before. CGV might thus contribute to the high
standing genetic variation observed in meningococcal
population since the conditions that induce such allelic
effects are rare in the history of the population, and
IMD would therefore result from the accidental unmask-
ing of meningococcal CGV in human blood. Further-
more, CGV is a subclass of variation with conditional
effects, either in form of G ×G or in G × E interaction.
Accordingly, not only by environmental perturbation
discussed above but also by genetic perturbation such as
deletion of relA we could experimentally uncover CGV
likely in genes required for amino acid biosynthesis and
ex vivo fitness (Fig. 5). Loci with such pleiotropic effects
known as genetic hubs or buffers are a common feature
of the genetics of gene expression [26] and their exist-
ence emerges from the concept of CGV [36]. These
genes are important for buffering both environmental
change and stochastic variation thus ensuring environ-
mental and stochastic resilience. Rather surprisingly,
there have been only very few verified genetic hubs in
published genetical genomics studies to date. Based on
our observations and the published data on the physi-
ology of the stringent response in, e.g., E. coli we
hypothesize that it contributes to the phenotypic buffer-
ing of CGV in metabolic genes and that RelA in particu-
lar might constitute such a regulatory hub coincidentally
affecting also meningococcal virulence. Therefore, the
elucidation of the genetic variability and molecular
mechanisms of stress responses in N. meningitidis will be
important for the understanding of virulence evolution in
this commensal pathogen. Of note, whereas the variability
in the complement and/or sequence of genes coding for
surface antigens and metabolic functions, respectively,
among different meningococcal lineages and their poten-
tial role in meningococcal virulence have already been well
established (e.g. ref. [92–95]), the extent of sequence
variability in stress response genes and their possible
(See figure on previous page.)
Fig. 8 Graphical summary and hypothesis relating major findings of this work and published data. The figure is not intended to give a
comprehensive overview of the entire metabolism and stress responses in N. meningitidis but to illustrate pathways that link metabolism,
protein sequence and gene expression differences of selected (virulence-associated) genes and the pathogenesis of IMD as described in
the main text. Accordingly, genes and pathways that were highly expressed in MC58 in blood and/or that are strongly upregulated
between saliva and blood in MC58 are depicted in red, and genes and pathways that are highly expressed in α522 or that are strongly
upregulated between saliva and blood in α522 are depicted in green. Asterisks next to enzyme or protein names indicate that the
corresponding proteins have a less than average sequence similarity (BSRP < 0.958) or are entirely missing in strain α522. Arrows with plus
signs indicate (predominantly) activating regulatory interactions, and arrows with minus signs (predominantly) inhibitory regulatory
interactions. For further details and abbreviations see main text. The literature cited in the figure is indicated by bracketed numerals next to the
respective arrows: (1) Newcombe et al. (2005) [33], (2) Delany et al. (2006) [70], (3) Fantappie et al. (2009) [74], (4) Monaco et al. (2006) [87], (5) Huis in’t
Veld et al. (2011) [72], (6) Tala et al. (2011) [86], (7) Takahashi et al. (2015) [124], (8) Gunesekere et al. [71], (9) Criss and Seifert (2012) [38], (10) Seib et al.
(2006) [84], (11) Schmitt et al. (2009) [83], (12) Stevanin et al. (2007) [52], (13) Kobsar et al. (2011) [51], (14) Coureuil et al. (2014) [125], (15) Virji (2009)
[49], (16) Hellerud et al. (2015) [48]
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contribution to virulence differences in meningococci
have not been addressed so far. In addition, differences in
intergenic regions affecting gene expression regulation
[15] are often overlooked genetic determinants in the
search for bacterial virulence factors. The impaired fitness
of the α522 ATRrelA deletion mutant in human blood
(Fig. 5) provides an example of how regulatory evolution
via the integration of non-coding MITEs [79] into pro-
moter regions might contribute to fitness and conse-
quently virulence differences among bacterial strains in a
condition-dependent manner.
As all experimental approaches for studying meningo-
coccal infection biology this study has also its limita-
tions. First, the ex vivo conditions chosen might not be
truly representative for the in vivo situation. In particu-
lar, although meningococci have been found to be part
of the normal flora of the oral cavity [96] they actually
colonize the human nasopharynx where they immerse in
the liquid produced by nasopharyngeal epithelium and
constantly interact with epithelial cells. Therefore, saliva
produced by saliva glands may not be truly representa-
tive of this commensal environment. Second, given their
high genetic diversity [2] more meningococcal strains
need to be compared in order to see how generalizable
the transcriptomic results are with respect to the entire
species. Furthermore, any microarray-based approach
restricts the number of genes being compared to those
represented on the microarray. Comparative transcrip-
tome sequencing (RNA-Seq) approaches circumvent this
limitation and will allow not only for the detection of ex-
pression differences in non-coding small RNAs [97] but,
due to the higher dynamic range compared to microar-
rays [98], also for the detection of differences in genes
expressed at very low and very high levels, respectively.
Finally, as it was experimentally not possible to generate
relA and spoT complemented strains for cis/trans comple-
mentation assays, the phenotypes of the relA and relA spoT
deletion strains could in principle be also affected by polar
effects of the gene disruption on adjacent genes. This needs
to be addressed in further experimental studies.
In summary, the data presented in this work allow
novel hypotheses to be generated regarding the genetic
basis of meningococcal virulence differences. They in
particular warrant detailed analyses of the interaction
between meningococci and human neutrophils, the
physiological consequences of sequence differences in
cysH, glnE or glnBp, the strain-dependent regulation of
the stringent response in meningococci and how ATR
might affect the expression of adjacent genes. The large
transcriptomic data set provides per se an ex vivo gene
expression compendium and as such a valuable resource
for the meningococcal research community. Finally, our
experimental approach further allows to challenge these
findings in a larger panel of strains from carriage as well
as hyperinvasive lineages and to seek for other genetic
determinants affecting ex vivo fitness.
Conclusion
In the present work, we showed that despite identical
ex vivo phenotypes two genetically similar strains of N.
meningitidis displayed large differences in their tran-
scriptomes including numerous virulence genes and sub-
ject to environmental conditions. Consequently, the
often employed “model strain” approach might give mis-
leading results in genetically diverse species like N.
meningitidis which might not be representative for the
entire species. Furthermore, the finding that relA is con-
ditionally essential and likely contributes to the tran-
scriptional buffering of cryptic genetic variation in
metabolic genes potentially limits the universality of
RelA as a novel drug target [99]. Finally, beyond the
variation in the set of virulence genes observed in
“model” bacterial pathogens such as E. coli, the finding
that a short, non-coding repeat element affected menin-
gococcal fitness in a strain- and condition-dependent
manner highlights the importance also of regulatory evo-
lution in the emergence of virulence in commensal path-
ogens. Together, these findings demonstrate that “to
generalize results across genetic backgrounds, experi-
ments must be carried out across genetic backgrounds”
[25], and because the pathogenic nature of a microbe is
a quantitative trait resulting from multiple interacting
loci, with allelic effects that are sensitive to the environ-
mental conditions, best within a systems biological
framework. In this respect our experimental approach is
generic for the identification of loci that are associated
with the invasive phenotype also in other genetically
diverse commensal pathogens.
Methods
Strains and growth conditions
N. meningitidis serogroup B strain α522 (ST-35 CC) was
isolated from a healthy carrier in the course of the Bav-
arian Carriage Study [100], whereas strain MC58 (ST-32
CC) (Research Resource Identifier (RRID): SCR_002200)
has been isolated from a case of invasive disease [101]
(Table 1). Meningococcal strains were routinely grown on
Columbia blood agar (bioMérieux, Nürtingen, Germany).
Proteose peptone medium supplemented with Polyvitex
(bioMérieux, Nürtingen, Germany) (PPM+) and RPMI
1640 20 mM HEPES (Biochrom AG, Berlin, Germany)
were used to prepare liquid cultures of the meningococcal
strains. E. coli strain TOP10 cells (Invitrogen, Darmstadt,
Germany) were routinely cultivated on Luria-Bertani (LB)
agar or LB broth at 37 °C. Kanamycin and chlorampheni-
col were added when required to select for the deletion
mutants and complementing meningococcal strains at a
final concentration of 100 μg/ml and 7 μg/ml. Kanamycin
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and chloramphenicol were added at a final concentration
of 30 μg/ml to select E. coli TOP10 strains during the
cloning steps.
In vitro growth experiments
For the in vitro growth assays, strains were grown over-
night at 37 °C and in 5% CO2 on Columbia blood agar
(bioMérieux). The next day, bacterial cells were inocu-
lated in PPM+, meningococcal minimal medium
(MMM, adapted from refs. [85, 102]) or MMM supple-
mented with 2.10 mM L-cysteine and further amino
acids (Additional file 1: Figure S4) and grown at 37 °C
with shaking at 200 rpm on a laborytory shaker Certo-
mat ® H (Braun Melsungen AG, Melsungen, Germany)
for 1 h. Bacterial cells were then adjusted to an optical
density at 600 nm (OD600) of 0.1 using the WPA
Biowave CO8000 Cell Density Meter (Biochrom Ltd.,
Cambridge, UK) and further cultivated at 37 °C and
200 rpm, and for each time point growth measurements
were repeated three times.
Adhesion and invasion assays
Cell adhesion and invasion assays were performed with
human FaDu (ATCC® number HTB-43™, RRID:
CVCL_1218) and Detroit 562 (CLS number 300399/
p754_Detroit-562, RRID: CVCL_1171) nasopharyngeal
epithelial cell lines. The multiplicity of infection (MOI)
was adjusted to 10 in RPMI 1640 and the cells were
infected for 6 h at 37 °C with 5% CO2. The numbers of
adherent and intracellular bacteria were then assessed as
described in [103]. All infection experiments were per-
formed in duplicate and the experiments were repeated
at least three times.
Lipooligosaccharide typing and serum bactericidal assays
Lipooligosaccharide (LOS) immunotyping was per-
formed using ELISA as described in [103]. Each serum
bactericidal assay was repeated at least four times as
described in [104].
Sequencing and annotation of the N. meningitidis α522
genome
For de novo sequencing of the N. meningitidis α522 gen-
ome at 79-fold coverage, Roche/454 sequencing of 3-kb
paired-end libraries using the GS FLX Titanium chemis-
try (Roche Diagnostics, Penzberg, Germany) was com-
bined with Sanger sequencing of fosmid libraries
generated with vector pCC1FOS (EPICENTRE Biotech-
nologies, Madison, WI) and of PCR products for gap
closure on an ABI 3730XL sequencer (Applied Biosys-
tems, Foster City, CA). N. meningitidis α522 scaffolds
and unscaffolded contigs were arranged according to the
genome of the reference strain N. meningitidis MC58
(GenBank accession AE002098) using the Mauve Contig
Mover [105] and concatenated by 12-mer linkers
(CTAGCTAGCTAG) containing stop codons in all six
reading frames. The genome annotation system GenDB
2.0 [106] was used for automatic gene prediction and
annotation of the α522 genome employing standard pro-
cedures. The final assembly of the α522 draft genome
consisted of 21 contigs and comprised over 2.07 Mb
with about 2000 predicted coding sequences (Table 1).
Computational genome analyses
Genomes sequences were compared and visually
inspected for manual data curation using Mauve [107]
along with the Artemis Comparison Tool Release 5
[108] based on pairwise BLASTN alignments [109].
Orthologous genes were operationally defined as
MC58 genes with a single significant best BLASTN hit
in the α522 draft genome (E-value < 1/2000), corre-
sponding to at least 80% sequence identity over at least
90% of the sequence length. For pairwise coding se-
quence comparisons BLASTP bit score ratios (BSRP)
were computed from the bit scores (S’) using MC58 cod-
ing sequences as query and either the significant best hit
coding sequences from α522 (best hit) or MC58 (self-
hit) as subject sequences according to BSR = S’best hit/
S’self-hit as described in [110]. The encoded proteins were
classified according to the COG functional classification
scheme [37], and functional domains were assigned
using NCBI’s Conserved Domain Database (CDD) [111].
We further used PSORTb 3.0 for the prediction of the
subcellular localization of the encoded proteins [112].
Discriminative motif discovery was performed using
MEME version 4.8.1 [113] to identify overrepresented
bona fide TF binding sites within 200 bp regions upstream
of predicted ATG translational start codons among differ-
ently expressed gene sets and with a minimum motif
width of 2 bp and a maximum of 50 bp, respectively. Shuf-
fleseq from the EMBOSS software package [114] was used
for the randomization of 200 bp upstream sequences.
ATR sequences together with the adjacent up- and down-
stream 10 bp were extracted from the original Z2491
genome annotation published in ref. [115]. Consecutively,
the ATR consensus sequence obtained from a multiple
sequence alignment with MUSCLE [116] was used for
similarity searches in the genomes of MC58 and α522
with BLASTN [109], and promoter prediction in the grxB
– relA intergenic region was carried using a neural net-
work approach as implemented in PPP [117].
Collection and processing of human specimens
Donors for saliva and blood were selected based on (a)
not having a history of vaccination against N. meningiti-
dis serogroups A, B, C, W and Y, respectively, (b) not
having taken any antibiotics within 5 days prior sam-
pling, and (c) not currently being carriers of
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meningococci. Human saliva was collected from the do-
nors after stimulation with CRT paraffin (Ivoclar Viva-
dent GmbH, Ellwangen, Germany). The collected saliva
was processed via centrifugation at 4000 rpm for 10 min
followed by filter sterilization using 0.2 μm filters (Sar-
stedt, Nümbrecht, Germany) to eliminate all bacterial
and eukaryotic host cells from the sample. Human CSF
samples were obtained from the routine diagnostic la-
boratory at the Institute for Hygiene and Microbiology
of the University of Würzburg and tested for sterility
and the absence of antibiotics as well as leucocytes ac-
cording to established standard operating procedures.
The CSF and saliva samples were pooled and stored at
−20 °C. Prior to the experiment, the pooled CSF samples
were gassed with CO2 and pH was controlled to be in
the physiologic range between pH 7.0 – 7.5. Heparinized
human venous blood from four healthy donors (two
males and two females) was drawn fresh on the day of
the experiment and was used within an hour of
collection.
Ex vivo survival assays
Before exposure to human saliva, blood and cerebro-
spinal fluid bacterial strains were grown in PPM+
medium to mid log phase (OD600nm ~ 0.5 – 0.6). One
milliliter of the culture was harvested by centrifugation
and after washing with 1x PBS, the bacterial pellet was
resuspended in 1 ml of 1x PBS. Ten microliter of this
suspension corresponding to ~ 106 colony forming units
(cfu)/ml were inoculated into 1 ml of human saliva,
blood and cerebrospinal fluid, respectively, and incu-
bated at 37 °C with shaking. Aliquots were taken out
after 30 min, 60 min and 120 min and serial dilutions
were plated out on Columbia blood agar (bioMérieux)
to estimate the number of viable bacteria. Ex vivo infec-
tion experiments with human saliva and human CSF
were performed using pooled saliva and pooled CSF
samples, respectively, whereas ex vivo infections using
whole venous blood were performed individually with
each of the four blood samples and the isolated bacterial
RNAs were pooled prior further analysis.
Isolation of bacterial RNA
The meningococcal strains were grown in PPM+
medium to mid log phase (OD600nm ~ 0.5 – 0.6),
harvested by centrifugation and the bacterial pellets were
resuspended in equal volumes of pooled saliva, pooled
CSF and whole venous blood, respectively. To detect
transcriptional differences in both strains independent of
the exposure to human material PPM+ medium was
used as control, and all samples were incubated at 37 °C
with 5% CO2 for 30 min. Bacterial cells exposed to
PPM+, pooled saliva and pooled CSF, respectively,
were harvested by centrifugation at 4000 rpm for
10 min and shock frozen in liquid nitrogen for RNA
isolation. Blood suspensions containing bacteria were
centrifuged at 1000 rpm for 10 min to allow the
blood cells to settle down, and the supernatant con-
taining the bacterial cells were transferred to a fresh
tube and harvested by centrifugation at 4000 rpm for
10 min. The pellets were then washed with erythro-
cyte lysis buffer (Qiagen, Hilden, Germany) and the
bacterial pellet was shock frozen in liquid nitrogen
for further RNA isolation. From the bacterial pellets,
total RNA was isolated using TRIZOL® (Invitrogen
GmbH, Darmstadt, Germany) according to the manu-
facturer’s protocol with slight modifications with re-
spect to bacterial cell lysis. Contaminating DNA was
removed by treating the samples with DNAse
(Applied Biosystems) according to the manufacturer’s
protocol. Absence of meningococcal chromosomal DNA
was verified by PCR for the MLST housekeeping genes
fumC and adh. Absence of contaminating host DNA was
confirmed by PCR using primers Act-1 and Act-2 for the
eukaryotic ß actin gene. Quality analysis of the RNA was
performed using the Agilent 2100 Bioanalyzer (Agilent
Technologies, Böblingen, Germany) and the RNA integrity
factor was controlled to be > 7 in all cases as described by
the manufacturer. All experiments were performed in tripli-
cate to yield three RNA samples (replicates) for each strain
under the four ex vivo conditions, and intact total RNA
could be obtained for both strains and all conditions at
30 min of incubation (Additional file 1: Figure S7A and B).
Microarray hybridization and data analysis
We used a spotted 70-mer oligonucleotide microarray
comprising, amongst others, all 2063 open reading
frames of N. meningitidis strain MC58 (GenBank
AE002098). The layout of the microarray has been
deposited in NCBI’s Gene Expression Omnibus database
(http://www.ncbi.nlm.nih.gov/geo/) and is accessible
through the GEO series accession number GPL9200. To
allow for all possible pairwise comparisons of gene ex-
pression profiles we chose a common reference experi-
mental design, and aliquots from each of the 24 RNA
samples (isolated from the two strains under the four ex
vivo conditions with three replicates each as described
above) were pooled to form the common reference.
Probe labeling, slide hybridization and analyses of raw
data were performed as previously described [118] using
a Tecan HS 4800 Pro hybridization station (Tecan
Deutschland GmbH, Crailsheim, Germany) and a Gene-
pix professional 4200A scanner (MDS Analytical Tech-
nologies, Ismaning, Germany) with the Genpix Pro 6.0
gridding software. Briefly, spots that were automatically
reported as “Bad” or “Not found” by the Genepix Pro
software were flagged and ignored during further pro-
cessing. Likewise, spots that had a signal to noise ratio
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of < 3 were manually flagged as “Bad” and also ig-
nored during subsequent analysis. The resulting raw
data files were processed using the loess method for
within slide normalization and the rquantile method
for between slide normalization implemented in the R
language [119] package Limma of the Bioconductor
software project [120].
For further analyses, two data sets were generated
both comprising 24 microarrays, one for the analysis of
transcriptional changes only within strain MC58, and a
second one for the comparison of the transcriptomes be-
tween strain MC58 and strain α522. The first dataset
comprised almost the entire gene complement of strain
MC58. However, due particularly to the presence of
multiple, almost identical copies of the filamentous pro-
phage Nf and a large duplication in the MC58 genome
which both result in extensive within-genome cross
homologies, it was not possible to design specific oligo
probes for 76 genes. Consequently, to assess the tran-
scriptional changes in strain MC58 only 1987 open read-
ing frames were used and the resulting coverage is
therefore 96.3% (1987/2063) with respect to the Gen-
bank annotation AE002098. The second dataset was de-
signed to specifically analyze transcriptional differences
between both strains taking into account possible con-
founding effects due to sequence differences in ortholo-
gous genes and/or differences in the gene dosage
between both strains. Both factors might affect the
hybridization signal intensities of the respective oligo
probes in microarray comparisons. Therefore, for tran-
scriptome comparisons between both strains we selected
only those genes and corresponding oligo probes, re-
spectively, which met the following criteria: (i) all genes
in MC58 used for transcriptome comparisons must have
a single unique best BLASTN self-hit in the MC58 gen-
ome and a single unique best BLASTN hit in the α522
genome to exclude paralogous genes; (ii) the ratio be-
tween the BLASTN bit scores of their best hit in the
α522 genome and of the respective MC58 gene self-hits
must be greater than 0.6 to also exclude truncated CDSs;
(iii) all oligo probes must have been found to hybridize
with both genomes in a recently performed comparative
genome hybridization study including both strains [28];
and (iv) all oligo probes must hit the orthologous genes
in both genomes with fewer than eight mismatches over
their entire length (>90% sequence identity). These cri-
teria allowed us to examine the expression profile of
1450 genes between the two strains and in the four
different ex vivo conditions using the limma package.
We confirmed that there was no correlation between
(absolute) gene expression level differences among
strains and the percent sequence identity of the MC58
based oligonucleotides with their respective targets in
the α522 draft genome (pPearson > 0.1, Additional file 1:
Figure S7C), thus avoiding any strain bias in the expres-
sion data. Comparison of the expression levels of sixteen
genes in PPM+, saliva, blood and CSF further revealed a
good correlation between the microarray and the corre-
sponding qRT-PCR data (n = 43 measurements, Person’s
adjusted R2 = 0.74, pPearson < 10
−13). All expression data
are given in Additional file 2: S1.
Assessment and analysis of significantly differently
expressed genes
Using limma, only genes having a false discovery rate
(FDR) < 0.05 after applying the Benjamini-Hochberg
(BH) multiple testing correction and a log-odds (B-stat-
istic) > 3, corresponding to a greater than 95% probabil-
ity of being differentially expressed, were included in
further data analyses. Overrepresentation analyses were
performed using a contingency table and Fisher’s exact
test to assess whether a COG functional category [37]
was overrepresented among differently expressed genes.
Unless stated otherwise, for all comparisons of multiple
genes sets the Benjamini-Hochberg multiple testing cor-
rection was used with a FDR cut-off of 0.05.
Metabolic reconstructions of strain MC58 and α522
The metabolic network of strain MC58 was recon-
structed based on genes and reactions from the
Nmb_iTM560 model [55], missing reactions were added
according to references and KEGG database (Neisseria
meningitidis MC58, serogroup B model). Futile cycles
were eliminated and redundant reactions were removed
from the collection, to derive a condensed network ap-
plicable for direct flux balance analysis (full simulation,
not just sampling of modes). The generated model com-
prised 123 gene-associated enzymes and 129 metabo-
lites involved in glycolysis, the pentose phosphate
pathway and the TCA cycle. Furthermore, intermediary
metabolism included lactate, acetate and acetoacetate
metabolism, as well as amino acid metabolism, glutathi-
one metabolism, purine and pyrimidine metabolism.
Uptake transporters were taken into account if the
metabolite appeared either in the composition list of
human saliva or human blood as taken from ref. [58].
Network reconstruction was accomplished using the
YANAsquare software [56]. A metabolic model for strain
α522 was constructed in the same way, noting minor
differences in metabolism (see results for details).
Flux balance analysis of transcriptomic data
Flux computation was carried out by the YANAver-
gence package [57] and the Nmb_iTM560 metabolic
model [55] modified as described above to get all the
extreme pathways which describe the steady-state so-
lution space of this genome-scale metabolic network.
We used the normalized gene expression data
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described above to determine the corresponding en-
zyme activities encoded by genes that showed signifi-
cant expression differences between both strains in
saliva and blood, respectively. The activity of an en-
zyme complex comprised by different subunits was
defined by the average intensity of the corresponding
subunits, whereas the activity of a reaction catalyzed
by isoenzymes was determined by the total activities
of these encoding genes. Once convergence was
reached, we used the estimated flux distribution to
compute all the unmeasured enzyme activities.
Finally, the enzyme activities computed according to
our model were either compared between two condi-
tions for strain MC58 or between both strains in
human blood to investigate obvious differences.
Protein-protein interaction network analysis of
transcriptomic data
Protein-protein interaction network data for the core
genome of N. meningitidis strain MC58 have been ex-
tracted from the STRING database (version 9.0, http://
string-db.org) [54] yielding a total of 149,957 interactions
between 2.052 genes. Based on the edge probabilities of
the STRING database two microarray-specific networks
of medium (probability > 0.4) and high confidence (prob-
ability > 0.7) have been derived. For the integrated net-
work analysis the largest connected component of both
networks have been used, comprising 21,071 interactions
between 1,200 genes (medium confidence) and 4,360 in-
teractions between 783 genes (high confidence). For all
contrasts of interest p-values have been derived from the
limma analyses. For the integrated network analysis
node (gene) scores have been computed based on these
p-values as detailed in [53] using the routines imple-
mented in the R-package BioNet [121].
Quantitative real-time RT-PCR
Validation of the microarray data was performed using
the StepOnePlusTM Real-Time PCR system with SYBR-
Green (Applied Biosystems) as described in [122].
Briefly, 2 μg of DNA free RNA were reverse transcribed
and suitable dilutions of the cDNA were used as tem-
plate for quantification using the StepOnePlus™ Real-
Time PCR system. The relative amounts of the cDNAs
in the various samples were determined using the com-
parative CT method as described by the manufacturer.
NMB1592 and rpoC which were not found to be differ-
entially regulated under any of the conditions tested in
this study by the microarray experiment were used as
housekeeping genes for relative quantification of the in-
vestigated genes. All oligonucleotides used in this study
are listed in Additional file 1: Table S2.
Transcriptional start site mapping of relA with 5´ RACE
The transcriptional start site (TSS) of relA and grx in the
strains MC58 and α522 was determined using the 5’/3’
RACE Kit, 2nd Generation (Roche Applied Science,
Manheim, Germany) according to manufacturer’s proto-
col. Briefly, cDNA was prepared using DNA free RNA
from both the strains with a gene specific primer
(relAGSP1 for relA and grxGSP1 for grx) and the re-
agents of the 5’/3’ RACE Kit. After incorporation of the
poly(A) tail at the 5´end of the cDNA using the Terminal
Transferase in the 5’/3’ RACE Kit, the tailed cDNA was
amplified by PCR using the Oligo(dT) Anchor Primer
along with primers relAGSP2 and grxGSP2 for relA and
grxB, respectively (Additional file 1: Table S2). Both are
nested primers which bind internal on the cDNA gener-
ated by relAGSP1 and grxGSP1 primer. After confirm-
ation of the presence of a pure fragment of the expected
size by agarose gel electrophoresis, the DNA fragment
was purified using Qiagen PCR purification kit (Qiagen,
Hilden, Germany) and sequenced on a ABI PRISM®3130
Genetic Analyzer (Applied Biosystems) using standard
BigDye® Terminator v1.1 cycle sequencing chemistry
(Applied Biosystems) to identify the transcriptional start
site of the relA and grxB in both strains independently.
Construction of isogenic deletion and insertion mutants
Deletion mutants were generated in the genetic back-
ground of N. meningitidis strain MC58 and α522 by re-
placing the entire encoding sequence with a kanamycin or
a chloramphenicol resistance cassette (Additional file 1:
Figure S6). Approximately 600 bp fragments of the flank-
ing regions of the target genes were amplified by PCR from
N. meningitidis MC58 and α522 genomic DNA, respect-
ively. Primers used for generation of flanking regions (up-
and downstream) of target genes are listed in Additional
file 1: Table S2. Up- and downstream regions were created
with different restriction sites. Flanking regions were amp-
lified with Q5 high fidelity polymerase (NEB, Frankfurt,
Germany), purified, digested and ligated into the pBlue-
script (pBS-KS, Stratagene, Heidelberg, Germany). Con-
structs were moved into E. coli TOP10 cells (Invitrogen)
using chemical transformation technique. Deletion of the
AT rich repeat region in the 5´region of relA in strain α522
was achieved by restriction free cloning using megaprime
PCR. Around 600 bp regions upstream and downstream of
the ATR in α522 were amplified using oligonucleotides
where the 3´oligonucleotide of the upstream fragment had
a complementarity of about 25 bp to the 5´region of the
downstream fragment and similarly the 5´oligonucleotide
of the downstream fragment had a complementarity of
about 25 bp to the 3´region of the upstream fragment.
These two purified fragments were further used as template
for a fusion PCR to yield a fused DNA fragment containing
the upstream and downstream regions of the ATR in strain
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α522. This fusion fragment was cloned into the pBluescript
cloning vector, then transformed into strain α522 and dele-
tion of the ATR in the mutant strain was confirmed by
PCR and sequencing.
The insertion of the AT rich repeat region in the 5’
region of relA in strain MC58 was also achieved by
restriction free cloning using megaprime PCR, as de-
scribed above. Corresponding oligonucleotides were
listed in Additional file 1: Table S2. The resulting PCR
fusion fragment was then ligated into pBS-SK, cloned
into strain MC58 and insertion of the ATR in the mu-
tant strain was confirmed by PCR and sequencing.
The same method was used to create grxB deletion
mutants in strain α522 and MC58 (Additional file 1:
Figure S7A). Around 600 bp upstream and downstream
of grxB were amplified, fused by megaprime PCR to a
chloramphenicol resistance cassette and ligated into
cloning vector pBS-SK. The resulting plasmid, listed in
Additional file 1: Table S3, was then transformed into
strain α522 and MC58.
All plasmids used to generate the deletion and insertion
mutants are listed in Additional file 1: Table S3. Naturally
competent MC58 and α522 cells were transformed and se-
lected on GC agar plates containing kanamycin and/or
chloramphenicol. The resulting mutants and meningococ-
cal isolated were listed in Additional file 1: Table S4. The
correct insertion of the resistance cassettes was confirmed
by PCR and sequencing as well as by southern blot analysis
using Hybond N+ nylon membranes (GE Healthcare, Mun-
ich, Germany) and the DIG DNA labeling and detection
kits (Roche Applied Science, Mannheim, Germany) accord-
ing to the manufacturer’s instructions.
ppGpp extraction and quantification
Strains were grown over night at 37 °C and in 5% CO2 on
blood agar plates. The next day, bacterial cells were prein-
cubated in PPM+ medium at 37 °C and 200 rpm for
45 min, the optical density adjusted to OD600nm = 0.1 and
the bacteria cultured at 37 °C and 200 rpm in 50 ml of
PPM+ medium. At OD600nm values of 0.5 - 0.6 (mid log, ~
1.5 h) and ≤ 1.6 (late log, ~ 4–5 h) the cells were harvested
via centrifugation at 4 °C and 4000 rpm for 10 min in a
Heraeus Megafuge 1.0 R (Thermo Scientific) centrifuge.
The pellets were subsequently shock-frozen in liquid nitro-
gen and stored at −80 °C. For subsequent ppGpp extraction
the pellets were resuspended in 1.25 ml of ice-cold 2 M
formic acid and incubated on ice for 30 min. These samples
were subsequently centrifuged at 4 °C at 4000 rpm for
10 min and the supernatant filtered through a 0.2 μm filter
and stored at −20 °C until use.
For HPLC analyses, a Smartline HPLC system with a
flow rate of 1.3 ml/min. The samples were loaded under
initial conditions of 95% of solution A (Tris–HCl 20 mM,
pH 8) and 5% of solution B (Tris–HCl 20 mM, sodium
formiat, 1.5 M, pH 8) for 20 min. Then the solution B was
ramped up to 60% during 45 min. The column was washed
with 100% of solution B for 10 min and finally equilibrated
with 95% of A and 5% B for 15 min. Quantification was
performed using the ChromGate V3.3.2 software (Knauer,
Berlin, Germany). The ppGpp standard was purchased
from Trilink Biotechnologies. Standard curves were estab-
lished using a total of ten different ppGpp concentrations
ranging from 20 to 10000 pmol.
Additional files
Additional file 1: Contains supplemental results and discussion describing
the results of ex vivo cross-condition gene expression comparisons in strain
MC58 along with the corresponding supplemental references and the figure
legends to the supplemental Figures S1 to S8 as well as the supplemental
Tables S1 to S4. Figure S1. Experimental setup of the study. Figure S2.
Comparison of the N. meningitidis α522 and MC58 genomes. Figure S3.
qRT-PCR validation of ex vivo cross-strain expression differences in selected
putative virulence-associated and regulatory genes. Figure S4. Growth of
strain α522 in minimal medium supplemented with different combinations
of amino acids. Figure S5. Comparison of the stringent response in N. menin-
gitidis strain MC58 and α522. Figure S6. Genetic map of the relA and spoT
loci in the mutant strains. Figure S7. Quality assessment of total RNA and
microarray data. Figure S8. Discriminator regions in genes differently
expressed in different ex vivo conditions in MC58. Table S1. Strain α522
specific genes. Table S2. Oligonucleotides used in this study. Table S3.
Plasmids used in this study. Table S4. Strains used in this study. (ZIP 19627 kb)
Additional file 2: S1 is an Excel spread sheet containing the MC58
genome annotation data together with the results of the pairwise
genome comparison with α522 and the microarray data. (XLSX 418 kb)
Additional file 3: S2 is an Excel spread sheet containing the results
of the elementary mode analyses in human blood based on MC58
metabolic network model. (XLSX 18 kb)
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CFU: Colony-forming units; CGV: Cryptic genetic variation; CHOR: Chorismate;
CI: Confidence interval; CIT: Citrate; CO2: Carbon dioxide; CoA: Coenzyme A;
COG: Cluster of orthologous groups; CSF: Cerebrospinal fluid; Cys/CYS : Cysteine;
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